Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Another day, another president. Good morning! Today, we hear from ...